UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union

Clinical cancer research, 2014-03, Vol.20 (6), p.1458-1468

2014

Volltextzugriff (PDF)

The European Medicines Agency: An Overview of Its Mission, Responsibilities, and Recent Initiatives in Cancer Drug Regulation

Clinical cancer research, 2011-08, Vol.17 (16), p.5220-5225

2011

Volltextzugriff (PDF)

IIW Guidelines on Weld Quality in Relationship to Fatigue Strength

1st ed. 2016., 2016

Volltextzugriff (PDF)

Placebo-controlled trials and the Declaration of Helsinki

The Lancet (British edition), 2002-04, Vol.359 (9314), p.1337-1340

2002

Volltextzugriff (PDF)

The risk of whiplash-induced medical impairment in rear-end impacts for males and females in driver seat compared to front passenger seat

IATSS research, 2013-07, Vol.37 (1), p.8-11

2013

Volltextzugriff (PDF)

Hurdles in anticancer drug development from a regulatory perspective

Nature reviews. Clinical oncology, 2012-04, Vol.9 (4), p.236-243

2012

Volltextzugriff (PDF)

Hand Position on Steering Wheel During Driving

Traffic injury prevention, 2011-04, Vol.12 (2), p.187-190

Jonsson, Bertil

2011

Volltextzugriff (PDF)

Assessment of benefits and risks in development of targeted therapies for cancer – The view of regulatory authorities

Molecular oncology, 2015-05, Vol.9 (5), p.1034-1041

2015

Volltextzugriff (PDF)

Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?

European journal of cancer (1990), 2011-08, Vol.47 (12), p.1759-1762

2011

Volltextzugriff (PDF)

Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden — Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials

European neuropsychopharmacology, 2011-11, Vol.21 (11), p.781-788

2011

Volltextzugriff (PDF)

Hazards with mobile phones during driving. Time for a more stringent legislation and smarter technology according to a pilot study

Läkartidningen, 2010-09, Vol.107 (39), p.2320-2321

Jonsson, Bertil

2010

Volltextzugriff (PDF)

The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

European journal of cancer (1990), 2013-05, Vol.49 (7), p.1654-1661

2013

Volltextzugriff (PDF)

Mobilen i bilen en olycksrisk

Läkartidningen, 2010-09, Vol.107 (39), p.2320

Jonsson, Bertil

2010

Volltextzugriff (PDF)

Platelet response as the basis for approval in chronic immune (idiopathic) thrombocytopenic purpura (ITP): A regulatory perspective

American journal of hematology, 2012-10, Vol.87 (10), p.943-944

2012

Volltextzugriff (PDF)

Welding procedures for fatigue life improvement of the weld toe

Welding in the world, 2016-05, Vol.60 (3), p.573-580

2016

Volltextzugriff (PDF)

Development of Weld Quality Criteria Based on Fatigue Performance

Welding in the world, 2011, Vol.55 (11-12), p.79-88

2011

Volltextzugriff (PDF)

Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European Union : PRECISION MEDICINE

Clinical cancer research, 2014, Vol.20 (6), p.1458-1468

2014

Volltextzugriff (PDF)

Medical Product Agency about Multiferon: positive benefit-risk relation

Läkartidningen, 2010-12, Vol.107 (51-52), p.3301-3301

2010

Volltextzugriff (PDF)

Fatigue design of lightweight welded vehicle structures: influence of material and production procedures

Proceedings of the Institution of Mechanical Engineers. Part B, Journal of engineering manufacture, 2012-10, Vol.226 (10), p.1736-1744

2012

Volltextzugriff (PDF)

Targeted drugs a chance for a better cure

Läkartidningen, 2010-04, Vol.107 (16), p.1071-1074

2010

Volltextzugriff (PDF)

Weight optimization and fatigue design of a welded bogie beam structure in a construction equipment

Engineering failure analysis, 2012, Vol.19, p.63-76

2012

Volltextzugriff (PDF)

Implementing High Frequency Mechanical Impact in Industrial Components: A Case Study

Procedia engineering, 2013, Vol.66, p.202-215

2013

Volltextzugriff (PDF)

Weld Quality Assessment and Actions

Steel research international, 2006-12, Vol.77 (12), p.852-856

2006

Volltextzugriff (PDF)

Seat adjustment - capacity and repeatability among occupants in a modern car

Ergonomics, 2008-02, Vol.51 (2), p.232-241

2008

Volltextzugriff (PDF)

Fatigue Assessment and Lefm Analysis of Cruciform Joints Fabricated with Different Welding Processes

Welding in the world, 2008, Vol.52 (7-8), p.93-105

2008

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(149)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union

The European Medicines Agency: An Overview of Its Mission, Responsibilities, and Recent Initiatives in Cancer Drug Regulation

IIW Guidelines on Weld Quality in Relationship to Fatigue Strength

Placebo-controlled trials and the Declaration of Helsinki

The risk of whiplash-induced medical impairment in rear-end impacts for males and females in driver seat compared to front passenger seat

Hurdles in anticancer drug development from a regulatory perspective

Hand Position on Steering Wheel During Driving

Assessment of benefits and risks in development of targeted therapies for cancer – The view of regulatory authorities

Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?

Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden — Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials

Hazards with mobile phones during driving. Time for a more stringent legislation and smarter technology according to a pilot study

The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

Mobilen i bilen en olycksrisk

Platelet response as the basis for approval in chronic immune (idiopathic) thrombocytopenic purpura (ITP): A regulatory perspective

Welding procedures for fatigue life improvement of the weld toe

Development of Weld Quality Criteria Based on Fatigue Performance

Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European Union : PRECISION MEDICINE

Medical Product Agency about Multiferon: positive benefit-risk relation

Fatigue design of lightweight welded vehicle structures: influence of material and production procedures

Targeted drugs a chance for a better cure

Weight optimization and fatigue design of a welded bogie beam structure in a construction equipment

Implementing High Frequency Mechanical Impact in Industrial Components: A Case Study

Weld Quality Assessment and Actions

Seat adjustment - capacity and repeatability among occupants in a modern car

Fatigue Assessment and Lefm Analysis of Cruciform Joints Fabricated with Different Welding Processes

Suchergebnisse filtern